Icon
+91 94997 68112
Login Register

Tasigna - (150mg, 200mg Capsule oral)

NILOTINIB HYDROCHLORIDE MONOHYDRATE Novartis
150mg, 200mg Capsule oral
Less Than $1000 mn
Less Than 5
Less Than 5
More Than 5
 None
Less Than 5
 None
Tasigna (nilotinib) is a cancer medicine that interferes with the growth and spread of cancer cells in the body. Tasigna is used to treat a type of blood cancer called Philadelphia chromosome positive chronic myeloid leukemia (CML) in adults and children who are at least 1 year old
Yes
**** ** ** ***** *** *** ******* ** *** *********. ** ****** **** *** ******* ******* ***** **** *** ** ****** ******* ******** ** *** *, **** *** **** ** ********** *** ******* ******* **. **** *** ****** ******* ** ***** **** **** ***** ** *** ***. ****** ******** * ********* ******** *** ******* ** *** **** (*****://***.**********.***.***/**********_****/*********/****/*****************_***.***) *** *** *** *********.
Tasigna Patent 1 Patent 2 Patent 3 Patent 4 Patent 5 Patent 6 Patent 7
****** **** *** *** ********* *** ********* (***** ******) *** ********* *** ********* *** ********* *** ********* (***** ******)
**** ******* **** **** **** ** *** **, **** **** ** *** **, **** **** ** *** **, **** **** ** *** **, **** **** ** *** **, **** **** ** *** **, ****
Company FTF Status / 180 days exclusivity 30-Months stay Current Litigation Status Current Approval Status Likelihood of launch
****** *** \ ********* -**- *** ********* ******** *** ****** *******
**** ** \ ** *** **, **** ******* **** *** ****** *** ****
  1. *** *, **** : * ****-** ** ***** *** ***** ** *** *** *******.
  2. *** **, **** : ****** ******** * ********* ******** *** ******* (*****://***.**********.***.***/**********_****/*********/****/*****************_***.***) *** *** *** *********
  3. *** **, **** : **** ******** ******** ***** *** **** ** ******.
  4. *** *, **** : ******** **** **** **** ************ ** ****** ** '***, '***, '***, '***, '*** *** '***.

Tasigna - (50 mg; Capsule)

NILOTINIB HYDROCHLORIDE MONOHYDRATE Novartis
50 mg; Capsule
Less Than $1000 mn
Less Than 5
Less Than 5
More Than 5
 None
Less Than 5
 None
Tasigna is indicated for the treatment of adult patients with chronic phase and accelerated phase Philadelphia chromosome positive chronic myelogenous leukemia (Ph+ CML) resistant or intolerant to prior therapy that included imatinib
Yes
* **** ** ***** ** ******* *******. ********* ** ******** *** ******, ******* ****** ** ******* ****** ** **** ** *** (*****://***.***.***/********/*****/****/**********/******************/**********.***). ****** ******** * ********* ******** *** ******* ** *** **** (*****://***.**********.***.***/**********_****/*********/****/*****************_***.***) *** *** *** *********.
Tasigna Patent 1 Patent 2 Patent 3 Patent 4 Patent 5 Patent 6 Patent 7
****** **** *** *** ********* *** ********* *** ********* *** ********* *** ********* *** *********
**** ******* **** **** **** ** *** **, **** **** ** *** **, **** **** ** *** **, **** **** ** *** **, **** **** ** *** **, **** **** ** *** **, ****
Company FTF Status / 180 days exclusivity 30-Months stay Current Litigation Status Current Approval Status Likelihood of launch
****** *** \ ********* -**- *** ********* ******** *** ****** *******
**** ** \ ** *** **, **** ******* **** *** ****** *** ****
  1. *** **, **** : * **** ** ***** ** ******* *******.
  2. *** **, **** : ****** ******** * ********* ******** *** ******* (*****://***.**********.***.***/**********_****/*********/****/*****************_***.***) *** *** *** *********
  3. *** **, **** : **** ******** ******** ***** *** **** ** ******.
  4. *** *, **** : ******** **** **** **** ************ ** ****** ** '***, '***, '***, '***, '*** *** '***.

Download ParaIV Report

Download ParaIV Detailed Report

To get detailed report Contact Us

ParaIV Advanced Search






Please contact contact@researchdelta.com to get more details.

Headquarters

Research Delta Advisor, G4,Sani Apartment, Bank of india lane, Ellora park, Vadodara 390023

+91 94997 68112

nimish@researchdelta.com

Products & Services

Para IV GenUS Pharmalysis Consulting Valuation

Quick Links

Home About Career Media Coverage Contact
© Research Delta, All Right Reserved.